Combination of ALpelisib and Trametinib in progressive REfractory Meningiomas
Phase 1
- Conditions
- MenangiomasTherapeutic area: Diseases [C] - Nervous System Diseases [C10]Therapeutic area: Diseases [C] - Neoplasms [C04]
- Registration Number
- CTIS2024-515836-61-00
- Lead Sponsor
- Centre Hospitalier Regional De Marseille
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method